Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-22851

Single-particle
6.6 Å
EMD-22851
3D View Gallery
Deposition: 13/10/2020
Map released: 28/04/2021
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-22851
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7kfe summary report (pdf.gz) Map and 7kfe FULL report (pdf.gz)
EMICSS annotations (xml)

Bundibugyo virus GP (mucin deleted) bound to antibody Fab BDBV-329 and EBOV-515

EMD-22851

Single-particle
6.6 Å
EMD-22851
3D View Gallery
Deposition: 13/10/2020
Map released: 28/04/2021
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Bundibugyo ebolavirus, Homo sapiens
Sample: Bundibugyo virus GP (mucin deleted) bound to antibody Fab EBOV-329 and EBOV-515
Fitted models: 7kfe

Deposition Authors: Murin CD, Ward AB
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies.
Murin CD, Gilchuk P, Ilinykh PA, Huang K , Kuzmina N, Shen X, Bruhn JF, Bryan AL, Davidson E, Doranz BJ, Williamson LE, Copps J, Alkutkar T, Flyak AI, Bukreyev A, Crowe Jr JE, Ward AB
(2021) Cell Rep , 35 , 108984 - 108984
PUBMED: 33852862
DOI: doi:10.1016/j.celrep.2021.108984
ISSN: 2211-1247